1428
G. Bashiardes et al.
LETTER
71.6 (C-3, C-4 et C-5), 86.5 (C-6), 126.5 (C-12), 127.6,
127.7 (C-11, C-13, C-10, C-14), 143.4 (C-9), 168.4, 169.2,
170.1, 170.5 (C=O) ppm.
IR: 3023 s (arom. =CH), 2966 m, 2930 w (CHn), 1742 s
(C=O), 1538 w, 1493 w, 1448 s (arom. C=C), 1372 s (C-N),
1217 s (C-O), 754 s, 703 s (arom. C-H) cm–1.
20), 135.8 (C-9), 142.1 (C-15), 168.4, 169.3, 169.7, 170.5
(C=O) ppm.
IR: 3020 m (arom. =CH), 2989 s, 2934 m (CHn), 1741 s
(C=O), 1497 m, 1450 m (arom. C=C), 1370 s (C-N), 1218 s
(C-O), 755 s, 701 s (arom. C-H) cm–1.
Compound 12b:
Compound 12a Major Conformer:
1H NMR (CDCl3): d = 2.16 (s, 12 H, CH3-CO-), 2.54 (s, 3 H,
H-8), 2.74 (dd, J3,3bis = 13.9 Hz, J3-7a = 7.1 Hz, 1 H, H-3),
3.10 (d, J3bis,3 = 13.9 Hz, 1 H, H-3bis), 3.58–3.60 (m, 1 H, H-
7a), 5.00–5.60 (m, 4 H, H-4, H-5, H-6, H-7), 7.23–7.39 (m,
5 H, H-10, H-11, H-12, H-13, H-14) ppm.
1H NMR (CDCl3): d = 1.99, 2.02, 2.04, 2.13 (4 s, 12 H, CH3),
2.27 (dd, J8,8bis = 13.0 Hz, J8,7a = 10.0 Hz, 1 H, H-8), 3.01 (d,
J8bis,8 = 13.0 Hz, 1 H, H-8bis), 3.60 (dd, J7a,8 = 10.0 Hz,
J7a,7 = 2.0 Hz, 1 H, H-7a), 4.18 (d, J3,3bis = 13.4 Hz, 1 H, H-
3), 4.21 (d, J3bis,3 = 13.4 Hz, 1 H, H-3bis), 5.11 (dd, J7,6 = 8.8
Hz, J7,7a = 2.0 Hz, 1 H, H-7), 5.31 (d, J4,5 = 8.6 Hz, 1 H, H-
4), 5.40 (dd, J5,4 = 8.6 Hz, J5,6 = 1.4 Hz, 1 H, H-5), 5.43 (dd,
13C NMR (CDCl3): d = 20.3, 20.8, 21.0, 21.1 (CH3-CO-),
33.8 (C-3), 47.0 (C-8), 63.1 (C-7a), 71.3 (C-7), 71.4, 71.5,
71.6 (C-4, C-5, C-6), 86.5 (C-3a), 126.5 (C-12), 127.6, 127.7
(C-11, C-13, C-10, C-14), 143.4 (C-9), 168.4, 169.2, 170.1,
170.5 (C=O) ppm.
J6,7 = 8.8 Hz, J6,5 = 1.4 Hz, 1 H, H-6), 7.13–7.31 (m, 10 H,
H-arom.) ppm.
13C NMR (CDCl3): d = 20.1, 20.5, 20.9, 21.0 (CH3), 34.6 (C-
3), 62.9 (C-8), 63.9 (C-7a), 70.2 (C-7), 73.5, 73.6 (C-5, C-6),
74.1 (C-4), 87.0 (C-3a), 126.1, 128.0, 128.2, 128.6, 129.8
(C-10, C-11, C-12, C-13, C-14, C-16, C-17, C-18, C-19, C-
20), 134.3 (C-9), 140.0 (C-15), 168.4, 169.3, 169.7, 170.5
(C=O) ppm.
IR: 3020 m (arom. =CH), 2989 s, 2934 m (CHn), 1741 s
(C=O), 1497 m, 1450 m (arom. C=C), 1370 s (C-N), 1218 s
(C-O), 755 s, 701 s (arom. C-H) cm–1.
IR: 3023 s (arom. =CH), 2966 m, 2930 w (CHn), 1742 F
(C=O), 1538 w, 1493 w, 1448 s (arom. C=C), 1372 s (C-N),
1217 s (C-O), 754 s, 703 s (arom. C-H) cm–1.
(16) (a) Perreux, L.; Loupy, A. Tetrahedron 2001, 57, 9199; and
references therein. (b) Bashiardes, G.; Safir, I.; Said
Mohamed, A.; Barbot, F.; Laduranty, J. Org. Lett. 2003, 5,
4915. (c) De La Hoz, A.; Diaz-Ortiz, A.; Langa, F. In
Microwaves in Organic Synthesis; Loupy, A., Ed.; Wiley-
VCH: Germany, 2003.
Compound 12a Minor Conformer:
(17) Typical procedure for the synthesis of (3aS,4R,5S,6R,7S,
7aS)-1-methyl-3a-phenyloctahydrobenzo[c]isoxazole-
4,5,6,7-tetraol tetraacetate 12c.
1H NMR (CDCl3): d = 1.99, 2.02, 2.04, 2.13 (4 s, 12 H, CH3),
2.81 (dd, J8,8bis = 13.8 Hz, J8,7a = 6.7 Hz, 1 H, H-8), 3.19 (d,
J8bis,8 = 13.8 Hz, 1 H, H-8bis), 3.57 (d, J3,3bis = 12.9 Hz, 1 H,
H-3), 3.86 (dd, J7a,8 = 6.7 Hz, J7a,7 = 3.9 Hz, 1 H, H-7a),
3.86–3.96 (m, 2 H, H-6, H-4), 3.91 (d, J3bis,3 = 12.9 Hz, 1 H,
H-3bis), 5.04 (dd, J5,4 = 4.1 Hz, J5,6 = 1.3 Hz, 1 H, H-5), 5.17
(dd, J7,7a = 3.9 Hz, J7,6 = 3.8 Hz, 1 H, H-7), 7.13–7.31 (m, 10
H, H-arom.) ppm.
Microwave conditions: in a pyrex test tube (2 × 15),
NaHCO3 (218 mg, 2.6·10–3 mol, 2.6 equiv), N-isopropyl-
hydroxylamine hydrochloride (290 mg, 2.6·10–3 mol, 2.6
equiv), carbohydrate 10 (252 mg, 1.0·10–3 mol) and 80% aq
EtOH (1 mL) were submitted to microwave irradiations
(CEM Discover apparatus. Settings: 70 °C, 100 W) during
80 min. After cooling and the solvent evaporated under
reduced pressure, the crude product was acetylated and
purified as in Ref. 15.
13C NMR (CDCl3): d = 20.1, 20.5, 20.9, 21.0 (CH3), 34.3 (C-
3), 62.1 (C-8), 66.2 (C-7a), 71.9 (C-7), 72.4, 72.6 (C-4, C-6),
75.5 (C-5), 88.2 (C-3a), 126.7, 127.7, 127.8, 128.4, 128.9
(C-10, C-11, C-12, C-13, C-14, C-16, C-17, C-18, C-19, C-
Synlett 2005, No. 9, 1425–1428 © Thieme Stuttgart · New York